Cas No.: 1228992-90-2
PRODUCT INFORMATION
Description
Cyclo(RGDfK(Mal)) is a maleimide-modified cyclic pentapeptide designed to mimic extracellular matrix interactions, thereby enhancing cellular adhesion. Its RGD motif targets integrins, while the maleimide group allows for covalent conjugation. It is a critical component for functionalizing advanced 3D biomaterial scaffolds, enabling scalable stem cell culture and controlled expansion under physiologically relevant in vitro conditions.
Molecular Weight
754.79
Purity
> 95%
Formula
C₃₄H₄₆N₁₀O₁₀
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys(MAL)]
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- Cyclic(YCDGFYACYMDV) Targeting Peptide (CAT#: OLY-1025-YS-6)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
- FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.